128 related articles for article (PubMed ID: 32776737)
1. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
Coskun FR; Percin-Pacal F; Emrence Z; Ar MC; Abaci N; Unuvar A; Eskazan AE; Elverdi T; Salihoglu A; Seflekci Y; Karakas Z; Soysal T; Sirma-Ekmekci S
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776737
[TBL] [Abstract][Full Text] [Related]
2. Clarifying the impact of polycomb complex component disruption in human cancers.
Yamamoto Y; Abe A; Emi N
Mol Cancer Res; 2014 Apr; 12(4):479-84. PubMed ID: 24515802
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
[TBL] [Abstract][Full Text] [Related]
4. BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.
de Rooij JD; van den Heuvel-Eibrink MM; Hermkens MC; Verboon LJ; Arentsen-Peters ST; Fornerod M; Baruchel A; Stary J; Reinhardt D; de Haas V; Pieters R; Zwaan CM
Haematologica; 2015 May; 100(5):e194-5. PubMed ID: 25596268
[No Abstract] [Full Text] [Related]
5. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].
Cen YX; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2004-2010. PubMed ID: 33283733
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-Function Mutations of
Eckardt JN; Stasik S; Kramer M; Röllig C; Krämer A; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Frickhofen N; Noppeney R; Kaiser U; Baldus CD; Kaufmann M; Rácil Z; Platzbecker U; Berdel WE; Mayer J; Serve H; Müller-Tidow C; Ehninger G; Stölzel F; Kroschinsky F; Schetelig J; Bornhäuser M; Thiede C; Middeke JM
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33926021
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.
Grossmann V; Tiacci E; Holmes AB; Kohlmann A; Martelli MP; Kern W; Spanhol-Rosseto A; Klein HU; Dugas M; Schindela S; Trifonov V; Schnittger S; Haferlach C; Bassan R; Wells VA; Spinelli O; Chan J; Rossi R; Baldoni S; De Carolis L; Goetze K; Serve H; Peceny R; Kreuzer KA; Oruzio D; Specchia G; Di Raimondo F; Fabbiano F; Sborgia M; Liso A; Farinelli L; Rambaldi A; Pasqualucci L; Rabadan R; Haferlach T; Falini B
Blood; 2011 Dec; 118(23):6153-63. PubMed ID: 22012066
[TBL] [Abstract][Full Text] [Related]
9. BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.
Schaefer EJ; Wang HC; Karp HQ; Meyer CA; Cejas P; Gearhart MD; Adelman ER; Fares I; Apffel A; Lim K; Xie Y; Gibson CJ; Schenone M; Murdock HM; Wang ES; Gondek LP; Carroll MP; Vedula RS; Winer ES; Garcia JS; Stone RM; Luskin MR; Carr SA; Long HW; Bardwell VJ; Figueroa ME; Lindsley RC
Blood Cancer Discov; 2022 Mar; 3(2):116-135. PubMed ID: 35015684
[TBL] [Abstract][Full Text] [Related]
10. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.
Li M; Collins R; Jiao Y; Ouillette P; Bixby D; Erba H; Vogelstein B; Kinzler KW; Papadopoulos N; Malek SN
Blood; 2011 Nov; 118(22):5914-7. PubMed ID: 21989985
[TBL] [Abstract][Full Text] [Related]
12. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
Tiacci E; Grossmann V; Martelli MP; Kohlmann A; Haferlach T; Falini B
Haematologica; 2012 Jan; 97(1):3-5. PubMed ID: 22210327
[No Abstract] [Full Text] [Related]
13. Structure and Role of BCOR PUFD in Noncanonical PRC1 Assembly and Disease.
Wong SJ; Senkovich O; Artigas JA; Gearhart MD; Ilangovan U; Graham DW; Abel KN; Yu T; Hinck AP; Bardwell VJ; Kim CA
Biochemistry; 2020 Jul; 59(29):2718-2728. PubMed ID: 32628469
[TBL] [Abstract][Full Text] [Related]
14. BCOR gene alterations in hematologic diseases.
Sportoletti P; Sorcini D; Falini B
Blood; 2021 Dec; 138(24):2455-2468. PubMed ID: 33945606
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia.
Honda A; Koya J; Yoshimi A; Miyauchi M; Taoka K; Kataoka K; Arai S; Kurokawa M
Exp Hematol; 2021 Sep; 101-102():42-48.e11. PubMed ID: 34333045
[TBL] [Abstract][Full Text] [Related]
16. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
[TBL] [Abstract][Full Text] [Related]
17. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
[TBL] [Abstract][Full Text] [Related]
18. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract][Full Text] [Related]
19. BCOR regulates myeloid cell proliferation and differentiation.
Cao Q; Gearhart MD; Gery S; Shojaee S; Yang H; Sun H; Lin DC; Bai JW; Mead M; Zhao Z; Chen Q; Chien WW; Alkan S; Alpermann T; Haferlach T; Müschen M; Bardwell VJ; Koeffler HP
Leukemia; 2016 May; 30(5):1155-65. PubMed ID: 26847029
[TBL] [Abstract][Full Text] [Related]
20. BCOR/BCORL1 mutated hypergranular cells mimicking acute promyelocytic leukemia.
Lebecque B; Dannus LT
Blood; 2023 May; 141(18):2283. PubMed ID: 37140950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
